Poster abstract: The Sustainability of 3D Printing & Microfluidics in Pharmaceutical Manufacturing

Collette O'Hagan, Edward Weaver, Dimitrios A. Lamprou*

*Corresponding author for this work

Research output: Contribution to conferenceAbstractpeer-review

Abstract

The global acceptance of human driven climate change has reframed the future priorities of many industries. Finding solutions to both limit and counteract the climate emergency has become a pressing matter of increasing concern. The pharmaceutical industry is not immune from either the concerns or innovations that are born from this emergency. To promote sustainability during pharmaceutical manufacturing, it’s important to identify the factors within a supply chain and manufacturing process that could be altered to improve the overall environmental sustainability. This report assesses the sustainability potential of additive manufacturing (AM) and microfluidics (MF), and what impact this could have on the wider pharmaceutical industry.
Original languageEnglish
Publication statusPublished - 25 May 2022
EventUnited Kingdom & Ireland Controlled Release Society Symposium 2022 - University of Manchester, Manchester, United Kingdom
Duration: 09 Jun 202210 Jun 2022
https://www.ukicrs.org/2022-symposium.html

Conference

ConferenceUnited Kingdom & Ireland Controlled Release Society Symposium 2022
Abbreviated titleUKICRS 2022
Country/TerritoryUnited Kingdom
CityManchester
Period09/06/202210/06/2022
Internet address

Keywords

  • 3D Printing
  • Emerging Technologies
  • Sustainability
  • Microfluidics
  • Pharmaceutical Manufacturing
  • PESTLE

Fingerprint

Dive into the research topics of 'Poster abstract: The Sustainability of 3D Printing & Microfluidics in Pharmaceutical Manufacturing'. Together they form a unique fingerprint.

Cite this